Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Sionis A; SEC Working Group for the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure:; Sionis Green A, Manito Lorite N, Bueno H, Coca Payeras A, Díaz Molina B, González Juanatey JR, Ruilope Urioste LM, Zamorano Gómez JL; Expert Reviewers for the 2016 ESC Guidelines for the Treatment of Acute and Chronic Heart Failure:; Almenar Bonet L, Ariza Solé A, Bover Freire R, Lambert Rodríguez JL, López de Sá E, López Fernández S, Martín Asenjo R, Mirabet Pérez S, Pascual Figal D, Segovia Cubero J, Varela Román A; SEC Guidelines Committee:; San Román Calvar JA, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marin Ortuño F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis Green A, Vázquez García R. Sionis A, et al. Among authors: gonzalez juanatey jr. Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1119-1125. doi: 10.1016/j.rec.2016.10.015. Rev Esp Cardiol (Engl Ed). 2016. PMID: 27894486 English, Spanish. No abstract available.
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. Ponikowski P, et al. Among authors: gonzalez juanatey jr. Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167. doi: 10.1016/j.rec.2016.11.005. Rev Esp Cardiol (Engl Ed). 2016. PMID: 27894487 English, Spanish. No abstract available.
Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
SEC Working Group for the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee. SEC Working Group for the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):458-465. doi: 10.1016/j.rec.2021.11.023. Epub 2022 Feb 18. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35190290 English, Spanish. No abstract available.
Differential effect of β-blockers for heart rate control in coronary artery disease.
Cordero A, Bertomeu-González V, Mazón P, Moreno-Arribas J, Fácila L, Bueno H, González-Juanatey JR, Bertomeu-Martínez V. Cordero A, et al. Among authors: gonzalez juanatey jr. Clin Cardiol. 2011 Dec;34(12):748-54. doi: 10.1002/clc.20981. Epub 2011 Nov 14. Clin Cardiol. 2011. PMID: 22083944 Free PMC article.
"Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?".
Abu-Assi E, Ferreira-González I, Ribera A, Marsal JR, Cascant P, Heras M, Bueno H, Sánchez PL, Arós F, Marrugat J, García-Dorado D, Peña-Gil C, González-Juanatey JR, Permanyer-Miralda G. Abu-Assi E, et al. Among authors: gonzalez juanatey jr. Am Heart J. 2010 Nov;160(5):826-834.e1-3. doi: 10.1016/j.ahj.2010.06.053. Am Heart J. 2010. PMID: 21095268
Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.
González-Juanatey JR, Álvarez-Sabin J, Lobos JM, Martínez-Rubio A, Reverter JC, Oyagüez I, González-Rojas N, Becerra V. González-Juanatey JR, et al. Among authors: gonzalez rojas n. Rev Esp Cardiol (Engl Ed). 2012 Oct;65(10):901-10. doi: 10.1016/j.recesp.2012.06.006. Epub 2012 Sep 6. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22958943 English, Spanish.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?
Raposeiras-Roubín S, Abu-Assi E, Redondo-Diéguez A, González-Ferreiro R, López-López A, Bouzas-Cruz N, Castiñeira-Busto M, Peña Gil C, García-Acuña JM, González-Juanatey JR. Raposeiras-Roubín S, et al. Among authors: gonzalez ferreiro r, gonzalez juanatey jr. Rev Esp Cardiol (Engl Ed). 2015 Jul;68(7):585-91. doi: 10.1016/j.rec.2014.07.028. Epub 2014 Dec 13. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25511558
857 results